Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis [Phase 2]
Open-label extension study to assess long-term safety and efficacy of ESK-001 in plaque psoriasis (Phase 2).
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Guselkumab Immunogenetics [Phase 4]
Phase 4 clinical trial update for guselkumab investigating immunogenetics in psoriasis, including guttate and plaque psoriasis, currently no…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)
An observational study validating the DermCLCI-p instrument for cumulative life course impairment in adults with moderate to severe chronic …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial is evaluating deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis, assessing…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
This is a Phase 2 trial update for ORKA-001 versus placebo in moderate-to-severe plaque psoriasis; the study is currently ACTIVE_NOT_RECRUIT…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of IRX4204 for mild-to-moderate plaque psoriasis has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
An observational real-world study examining the use of tildrakizumab in adults with moderate to severe plaque psoriasis in routine clinical …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2, Phase 3]
A clinical trial evaluating CMS-D001 tablets for adults with moderate to severe plaque psoriasis, currently in Phase 2/Phase 3 and not yet r…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 study evaluating the efficacy and safety of bimekizumab in Chinese adults with moderate to severe plaque psoriasis has completed w…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: A Registry of Patients With Moderate to Severe Plaque Psoriasis
This is a completed clinical trial registry update for patients with moderate to severe plaque psoriasis, sponsored by Novartis.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Role of Insulin Action in Psoriasis Pathogenesis
Columbia University sponsored a clinical trial investigating the role of insulin action in psoriasis pathogenesis has been terminated. The s…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. [Phase 1]
A Phase 1 study evaluating the safety and tolerability of the CAN10 antibody in healthy subjects and in people with plaque psoriasis has com…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Treatment of Moderate to Severe Plaque Psoriasis [Phase 2]
This document notes the completion of a Phase 2 clinical trial evaluating an investigational therapy for moderate to severe plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis [Phase 1]
Phase I trial evaluating a single subcutaneous or intravenous dose of SHR-1139 in healthy Chinese subjects and multiple subcutaneous doses i…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia [Phase 4]
Phase 4 clinical trial evaluating the combination of vunakizumab and recaticimab for moderate to severe plaque psoriasis with dyslipidemia; …
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study evaluating SCD-044 for moderate to severe plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 evaluation of TAK-279 for moderate-to-severe plaque psoriasis; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO) [Phase 3]
Phase 3 trial evaluating apremilast 30 mg twice daily in Chinese adults with moderate to severe plaque psoriasis has been completed, assessi…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects [Phase 1]
A Phase 1 study comparing pharmacokinetics and safety of Celltrion's CT-P52 against US-licensed ixekizumab (Taltz) in healthy participants.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis [Phase 2]
Phase 2 study of JNJ-77242113 in adults with moderate-to-severe plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
A real-world study evaluating the safety and effectiveness of secukinumab in pediatric patients with plaque psoriasis in China has completed…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This is a Phase 3 clinical trial update evaluating the efficacy and safety of apremilast in Japanese pediatric participants with moderate to…